Relay Therapeutics RLAY

$ 4.7 0.86%

Quarterly report 2024-Q3
added 11-06-2024

Relay Therapeutics Balance Sheet 2011-2024 | RLAY

Annual Balance Sheet Relay Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-90.3 M	-94.1 M	-260 M	-	-17.1 M	-421 M	-	-	-	-	-	-	-
Long Term Debt	48.5 M	53.5 M	21.1 M	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	4.96 M	4.28 M	1.84 M	1.52 M	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	562 M	533 M	-	-	-	-	-	-	-
Total Current Liabilities	30.3 M	63.7 M	24.3 M	13.6 M	-	-	-	-	-	-	-	-	-
Total Liabilities	92 M	150 M	111 M	36.5 M	574 M	540 M	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-1.4 B	-1.06 B	-768 M	-404 M	-189 M	-114 M	-	-	-	-	-	-	-
Total Assets	844 M	1.1 B	1.01 B	800 M	393 M	429 M	-	-	-	-	-	-	-
Cash and Cash Equivalents	144 M	152 M	283 M	448 M	42 M	422 M	-	-	-	-	-	-	-
Book Value	752 M	950 M	898 M	763 M	-180 M	-111 M	-	-	-	-	-	-	-
Total Shareholders Equity	752 M	950 M	898 M	763 M	-180 M	-111 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Relay Therapeutics

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	44.3 M	45.8 M	47.2 M	48.5 M	49.8 M	51.1 M	52.3 M	53.5 M	54.6 M	-	20.6 M	21.1 M	21.5 M	22 M	22.5 M	22.9 M	22.9 M	22.9 M	22.9 M	23.6 M	23.6 M	23.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	91.3 M	90.8 M	95.7 M	92 M	129 M	152 M	154 M	150 M	169 M	-	108 M	111 M	101 M	95.9 M	38.6 M	36.5 M	36.5 M	36.5 M	36.5 M	35.7 M	35.7 M	35.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	24 K	15 K	-	-	-	-	166 K	248 K	331 K	414 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-1.66 B	-1.57 B	-1.48 B	-1.4 B	-1.32 B	-1.25 B	-1.15 B	-1.06 B	-991 M	-	-830 M	-768 M	-701 M	-640 M	-446 M	-404 M	-404 M	-404 M	-404 M	-189 M	-189 M	-189 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	930 M	773 M	841 M	844 M	907 M	962 M	1.04 B	1.1 B	1.17 B	-	950 M	1.01 B	672 M	714 M	771 M	800 M	800 M	800 M	800 M	393 M	393 M	393 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	152 M	134 M	153 M	144 M	151 M	146 M	161 M	152 M	355 M	108 M	119 M	280 M	229 M	260 M	263 M	448 M	448 M	448 M	448 M	42 M	42 M	42 M	-	422 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	839 M	682 M	746 M	752 M	778 M	810 M	883 M	950 M	1 B	-	842 M	898 M	571 M	619 M	733 M	763 M	763 M	763 M	763 M	357 M	357 M	357 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	839 M	682 M	746 M	752 M	778 M	810 M	883 M	950 M	1 B	780 M	842 M	898 M	571 M	619 M	733 M	763 M	763 M	763 M	763 M	-180 M	-180 M	-180 M	-124 M	-111 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency